Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02486120 · ClinicalTrials.gov registry record
Are Genetic Counselors Screening for Adolescent Suicide Risk?
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 267
- Enrollment target
NCT02486120: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT02486120 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 267 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02486120 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 267 participants
- Enrollment target
Study Summary
Background: \- Suicide is one of the main causes of death for adolescents in the U.S. The most effective way to decrease suicide is by training doctors to recognize the risk factors in their clients. One risk factor for suicide is chronic illness. So pediatric genetic counselors come across high-risk clients. But the suicide risk assessment (SRA) practices of these counselors are not well known. Researchers want to study learn more about this. Objectives: \- To describe the practices, attitudes, and beliefs of genetic counselors about SRA of adolescents. Eligibility: \- Genetic counselors who see adolescents ages 10 21 Design: * A study will be open to a listserv for genetic counselors. * Participants will take a survey on their own. * The survey will be online on a secure website. * Participants will give data about themselves. This can include age, gender, job, etc. * The survey will be about 60 questions. * The survey will take around 20 25 minutes. * The questions are about participants experiences, practices, attitudes, and beliefs about SRA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2015-06-22 |
| Est. Completion | 2017-05-24 |
What the finished NCT02486120 record still lists
NCT02486120 is an observational study that tracks outcomes without assigning an intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02486120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02486120 about?
NCT02486120 is a clinical study titled "Are Genetic Counselors Screening for Adolescent Suicide Risk?". Background: \- Suicide is one of the main causes of death for adolescents in the U.S. The most effective way to decrease suicide is by training doctors to recognize the risk factors in their clients. One risk factor for suicide is chronic illness. So pediatric genetic counselors come across high-ri...
What is the current status of trial NCT02486120?
This trial is currently completed. The enrollment target is 267 participants. The study started on 2015-06-22. Estimated completion is 2017-05-24.
Who is sponsoring clinical trial NCT02486120?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04997109 · 267 participants · NA
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
- NCT05355701 · 267 participants · Phase 1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- NCT06203509 · 267 participants · NA
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI